adalimumab,ustekinumab
janssen,abbvie
['ibd']
 with a very comprehensive und thoughtful overview on 'upcoming next best therapeutic option for ibd' #uegweek22 
Professor of Medicine, Gastroenterologist, specializing in the care of patients with IBD.
National representative of Germany @ https://t.co/Qr0PthTmU8 ex @Y_ECCO_IBD chair